Biopolym. Cell. 2013; 29(1):11-20.
Огляди
Різноманіття функцій та ефектів кіспептину
1Матвієнко М. Г., 1Пустовалов А. С., 1Дзержинський М. Е.
  1. Навчально-науковий центр «Інститут біології»
    Київського національного університету імені Тараса Шевченка
    вул. Володимирська, 64/13, Київ, Україна, 01601

Abstract

Представлено короткий огляд літературних даних з дослідження властивостей та ефективності застосування кіспептину, зокрема, для регуляції ендокринних функцій організму. Проаналізовано численні результати експериментів з використанням кіспептину в молекулярній біології, репродуктивної медицині, ендокринології, а також при розробці вакцин проти злоякісних утворень. Згаданий пептид ініціює каскад змін, які призводять до пубертату. За наявними даними, кіспептин змінює активність залоз, які продукують статеві гормони, внаслідок чого він може знайти застосування у лікуванні захворювань, пов’язаних з порушенням пубертату, зокрема, аменореї у дівчат-підлітків. Дія цього пептиду обумовлена активацією клітин гіпоталамуса, що виділяють гонадоліберин, який регулює рівень гонадотропних гормонів. У той же час кіспептин активує репродуктивну систему, не порушуючи при цьому захисних механізмів організму. Видається перспективним більш поглиблене вивчення ефекту кіспептину на всі ланки гіпоталамо-гіпофізарно-гонадальної осі, а також дослідження нейроно-гліальних взаємодій у центральній нервовій системі під впливом даного пептиду.
Keywords: кіспептин, гонадотропний рилізинг-гормон, гіпоталамо-гіпофізарно-гонадальна вісь

References

[1] Kotani M., Detheux M., Vandenbogaerde A., Communi D., Vanderwinden J. M., Le Poul E., Brezillon S., Tyldesley R., SuarezHuerta N., Vandeput F., Blanpain C., Schiffmann S. N., Vassart G., Parmentier M. 2001 The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G proteincoupled receptor GPR54 J. Biol. Chem 276, N 37: 34631–34636.
[2] Muir A. I., Chamberlain L., Elshourbagy N. A., Michalovich D., Moore D. J., Calamari A., Szekeres P. G., Sarau H. M., Chambers J. K., Murdock P., Steplewski K., Shabon U., Miller J. E., Middleton S. E., Darker J. G., Larminie C. G., Wilson S., Bergsma D. J., Emson P., Faull R., Philpott K. L., Harrison D. 2001C. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KISS-1 J. Biol. Chem 276, N 31:28969–28975.
[3] Ohtaki T., Shintani Y., Honda S., Matsumoto H., Hori A., Kanehashi K., Terao Y., Kumano S., Takatsu Y., Masuda Y., Ishibashi Y., Watanabe T., Asada M., Yamada T., Suenaga M., Kitada C., Usuki S., Kurokawa T., Onda H., Nishimura O., Fujino M. 2001 Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor Nature 441, N 6837:613–617.
[4] Ergen A., Canbay E., Bugra D., Zeybek U., Yamaner S., Bulut T. 2012 Plasma Kisspeptin-54 levels in gastric cancer patients Int. J. Surg 10, N 5 P. 551–554.
[5] Tanaka M., Csabafi K., Telegdy G. 2012 Neurotransmissions of antidepressant-like effects of kisspeptin-13 Regul. Pept
[6] Navarro V. M., Castellano J. M, Fernandez-Fernandez R., Barreiro M. L., Roa J., Sanchez-Criado J. E., Aguilar E., Dieguez C., Pinilla L., Tena-Sempere M. 2004 Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide Endocrinology 145, N 10: 4565–4574.
[7] Lee J. H., Welch D. R. 1997 Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display Int. J. Cancer 71, N 6:1035–1044.
[8] Dhillo W. S., Chaudhri O. B., Patterson M., Thompson E. L., Murphy K. G., Badman M. K., McGowan B. M., Amber V., Patel S., Ghatei M. A., Bloom S. R. 2005 Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males J. Clin. Endocrinol. Metab 90, N 12:6609–6615.
[9] Dhillo W. S., Chaudhri O. B., Thompson E. L., Murphy K. G., Patterson M., Ramachandran R., Nijher G. K., Amber V., Kokkinos A., Donaldson M., Ghatei M. A., Bloom S. R. 2007 Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women J. Clin. Endocrinol. Metab 92, N 10:3958–3966.
[10] Matsui H., Tanaka A., Yokoyama K., Takatsu Y., Ishikawa K., Asami T., Nishizawa N., Suzuki A., Kumano S., Terada M., Kusaka M., Kitada C., Ohtaki T. 2012 Chronic administration of the metastin/kisspeptin analog KISS1-305 or the investigational agent TAK-448 suppresses hypothalamic pituitary gonadal function and depletes plasma testosterone in adult male rats Endocrinology 153, N 11 P. 5297–5308.
[11] Sonigo C., Binart N. 2012 Overview of the impact of kisspeptin on reproductive function Ann. Endocrinol. (Paris) 73, N 5 P. 448–458.
[12] Welch D. R., Chen P., Miele M. E., McGary C. T., Bower J. M., Stanbridge E. J., Weissman B. E. 1994 Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity Oncogene 9, N 1:255–262.
[13] Miele M. E., Robertson G., Lee J. H., Coleman A., McGary C. T., Fisher P. B., Lugo T. G., Welch D. R. 1996 Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6 Mol. Carcinog 15, N 4:284–299.
[14] Miele M. E., Jewett M. D., Goldberg S. F., Hyatt D. L., Morelli C., Gualandi F., Rimessi P., Hicks D. J., Weissman B. E., BarbantiBrodano G., Welch D. R. 2000 A human melanoma metastasis-suppressor locus maps to 6q16.3-q23 Int. J. Cancer 86, N 4:524–528.
[15] Lee J.H., Miele M. E., Hicks D. J., Phillips K. K., Trent J. M., Weissman B. E., Welch D. R. 1996 Kiss-1, a novel human malignant melanoma metastasis-supressor gene J. Natl Cancer Inst 88, N 23:1731–1737.
[16] West A., Vojta P. J., Welch D. R., Weissman B. E. 1998 Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1) Genomics 54, N 1:145–148.
[17] Shirasaki F., Takata M., Hatta N., Takehara K. 2001 Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23 Cancer Res 61, N 20:7422–7425.
[18] Stark A. M., Tongers K., Maass N., Mehdorn H. M., Held-Feindt J. 2005 Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases J. Cancer Res. Clin. Oncol 131, N 3:191–198.
[19] Kostadima L., Pentheroudakis G., Pavlidis N. 2007 The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer Anticancer Res 27, N 4B:2499–2504.
[20] Marot D., Bieche I., Aumas C., Esselin S., Bouquet C., Vacher S., Lazennec G., Perricaudet M., Kuttenn F., Lidereau R., de Roux N. 2007 High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors Endocr. Relat. Cancer 14, N 3:691–702.
[21] Mitchell D. C., Stafford L. J., Li D., Bar-Eli M., Liu M. 2007 Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130 Oncogene 26, N 12:1739–1747.
[22] Ringel M. D., Hardy E., Bernet V. J., Burch H. B., Schuppert F., Burman K. D., Saji M. Metastin receptor is overexpressed in pa pillary thyroid cancer and activates MAP kinase in thyroid cancer cells J. Clin. Endocrinol. Metab 2002 87, N 5:2399.
[23] Stathatos N., Bourdeau I., Espinosa A. V., Saji M., Vasko V. V., Burman K. D., Stratakis C. A., Ringel M. D. 2005 KiSS-1/G proteincoupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity J. Clin. Endocrinol. Metab 90, N 9:5432–5440.
[24] Zhang S. L., Yu Y., Jiang T., Lin B., Gao H. 2005 Expression and significance of KiSS-1 and its receptor GPR54 mRNA in epithelial ovarian cancer Zhonghua Fu Chan Ke Za Zhi 40, N 10:689–692.
[25] Hata K., Dhar D. K., Watanabe Y., Nakai H., Hoshiai H. 2007 Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer Eur. J. Cancer 43, N 9:1452–1459.
[26] Sanchez-Carbayo M., Belbin T. J., Scotlandi K., Prystowsky M., Baldini N., Childs G., Cordon-Cardo C. 2003 Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes Lab. Invest 83, N 4:507–517.
[27] Dhar D. K., Naora H., Kubota H., Maruyama R., Yoshimura H., Tonomoto Y., Tachibana M., Ono T., Otani H., Nagasue N. 2004 Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma Int. J. Cancer 111, N 6:868–872.
[28] Guan-Zhen Y., Ying C., Can-Rong N., Guo-Dong W., Jian-Xin Q., Jie-Jun W. 2007 Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer Int. J. Exp. Pathol 88, N 3:175–183.
[29] Yao H. L., Yang Z. L., Li Y. G., Liu G. W. 2007 In situ hybridization study on the expression of Kiss-1 and KAI-1 metastasis suppressor genes in gastric cancer Zhonghua Wei Chang Wai Ke Za Zhi 10, N 3:274–277.
[30] Ikeguchi M., Yamaguchi K., Kaibara N. 2004 Clinical significance of the loss of KISS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma Clin. Cancer Res 10, N 4:1379–1383.
[31] Ikeguchi M., Hirooka Y., Kaibara N. 2003 Quantitative reverse transcriptase polymerase chain reaction analysis for KISS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma J. Cancer Res. Clin. Oncol 129, N 9:531–535.
[32] Hou Y. K., Wang Y., Cong W. M., Wu M. C. 2007 Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma Ai Zheng 26, N 6:591–595.
[33] Masui T., Doi R., Mori T., Toyoda E., Koizumi M., Kami K., Ito D., Peiper S. C., Broach J. R., Oishi S., Niida A., Fujii N., Imamura M. 2004 Metastin and its variant forms suppress migration of pancreatic cancer cells Biochem. Biophys. Res. Commun 315, N 1:85–92.
[34] Liang S., Yang Z. L. 2007 Expression of KiSS-1 mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats Zhong Nan Da Xue Xue Bao Yi Xue Ban 32, N 1:109–113.
[35] Roseweir A. K., Kauffman A. S., Smith J. T., Guerriero K. A., Morgan K., Pielecka-Fortuna J., Pineda R., Gottsch M. L., TenaSempere M., Moenter S. M., Terasawa E., Clarke I. J., Steiner R. A., Millar R. P. 2009 Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation J. Neurosci 29, N 12 P. 3920–3929.
[36] Matsui H., Takatsu Y., Kumano S., Matsumoto H., Ohtaki T. 2004 Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat Biochem. Biophys. Res. Commun 320, N 2:383–388.
[37] Zohrabian V. M., Nandu H., Gulati N., Khitrov G., Zhao C., Mohan A., Demattia J., Braun A., Das K., Murali R., JhanwarUniyal M. Gene expression profiling of metastatic brain cancer Oncol. Rep 2007 18, N 2:321–328.
[38] Matvienko M. G., Pustovalov A. S., Buzynska N. O., Dzerzhinsky M. E. 2012 Morphofunctional changes in prepubertal rat testes under kisspeptin influence against blockade and activation of alpha-adrenergic receptors and melatonin administration. Bulletin of Luhansk National Taras Shevchenko University 1, N 17 P. 101–109.
[39] Matvienko M., Pustovalov A., Dzerzhinsky M. 2012 Morphofunctional changes in rat testes under kisspeptin influence against blockade and activation of alpha-adrenergic receptors and melatonin administration. Bulletin of Kyiv Taras Shevchenko National University. Biology 1, N 60 P. 41–43.
[40] Matvienko M. G., Pustovalov A. S., Buzynska N. O., Dzerzhinsky M. E. 2012 Morphofunctional changes in 24-month rat testes under kisspeptin influence against blockade and activation of alpha-adrenergic receptors and melatonin administration. Visnyk Problem Biologii i Meditsiny 2, N 3 P. 170–173.
[41] Arai A. C., Xia Y. F., Suzuki E., Kessler M., Civelli O.,Nothacker H. P. 2005 Cancer metastasis-suppressing peptide metastin upregulates excitatory synaptic transmission in hippocampal dentate granule cells J. Neurophysiol 94, N 5:3648–3652.
[42] Arai A. C., Orwig N. 2008 Factors that regulate KiSS1 gene expression in the hippocampus Brain Res 1243:10–18.
[43] Dzerzhinsky M., Matvienko M., Pustovalov A., Buzynska N. Kisspeptin influence on rat testes after administration of melatonin, prazosin, mezaton. 26th Conf. of Eur. Comparative Endocrinologists CECE 2012 (Zurich, Switzerland, 21–25 August 2012): Programme and abstract book.–Zurich, 2012.106.
[44] Matvienko M. G., Pustovalov A. S., Buzynska N. O., Dzerzhinsky M. E. Kisspeptin influence on rat testes after administration of prazosin, mezaton and melatonin: II Sci. Conf. of Young Physiologists «Physiology: from Molecules to the Body» (8–9 October, 2012).–Kyiv, 2012. 47p.
[45] Mead E. J., Maguire J. J., Kuc R. E., Davenport A. P. Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosis-prone vessels. Endocrinology 2007 148, N 1 P. 140–147.
[46] Kirby H., Mead E., Maguire J., Pitkin S., Colledge W. H., d'Anglemont de Tassigny X., Davenport A. P. 2008 Kisspeptins as inotropic agents in human and mouse heart Proc. Physiol. Soc 11 P. C152.
[47] Hauge-Evans A. C., Richardson C. C., Milne H. M., Christie M. R., Persaud S. J., Jones P. M. 2006 A role for kisspeptin in islet function Diabetologia 49, N 9:2131–2135.
[48] Bowe J. E., King A. J., Kinsey-Jones J. S., Foot V. L., Li X. F., O'Byrne K. T., Persaud S. J., Jones P. M. 2009 Kisspeptin stimulation of insulin secretion: mechanisms of action in mouse islets and rats Diabetologia 52, N 5:855–862.
[49] Silvestre R. A., Egido E. M., Hernandez R., Marco J. 2008 Kisspeptin13 inhibits insulin secretion without affecting glucagon or somatostatin release: study in the perfused rat pancreas J. Endocrinol 196, N 2:283–290.
[50] Lee J. H., Welch D. R. 1997 Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KISS-1 Cancer Res 57, N 12:2384–2387.
[51] Janneau J. L., Maldonado-Estrada J., Tachdjian G., Miran I., Motte N., Saulnier P., Sabourin J. C., Cote J. F., Simon B., Frydman R., Chaouat G., Bellet D. 2002 Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells J. Clin. Endocrinol. Metab 87, N 1:5336–5339.
[52] Bilban M., Ghaffari-Tabrizi N., Hintermann E., Bauer S., Molzer S., Zoratti C., Malli R., Sharabi A., Hiden U., Graier W., Knofler M., Andreae F., Wagner O., Quaranta V., Desoye G. 2004 Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts J. Cell Sci 117, Pt 8:1319–1328.
[53] Dhillo W.S., Savage P., Murphy K. G., Chaudhri O. B., Patterson M., Nijher G. M., Foggo V. M., Dancey G. S., Mitchell H., Seckl M. J., Ghatei M. A., Bloom S. R. 2006 Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment Am. J. Physiol. Endocrinol. Metab 291, N 5 E878–884.
[54] Horikoshi Y., Matsumoto H., Takatsu Y., Ohtaki T., Kitada C., Usuki S., Fujino M. 2003 Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placentaderived hormone in humans J. Clin. Endocrinol. Metab 88, N 2:914–919.
[55] Guimiot F., Chevrier L., Dreux S., Chevenne D., Caraty A., Delezoide A. L., de Roux N. 2012 Negative fetal FSH/LH regulation in late pregnancy is associated with declined kisspeptin/KISS1R expression in the tuberal hypothalamus J. Clin. Endocrinol. Metab 97, N 12 E2221–2229.
[56] Terao Y., Kumano S., Takatsu Y., Hattori M., Nishimura A., Ohtaki T., Shintani Y. 2004 Expression of KiSS-1, a metastasis suppressor gene, in trophoblast giant cells of the rat placenta Biochim. Biophys. Acta 1678, N 2–3:102–110.
[57] Qiao C., Wang C. H., Shang T., Lin Q. D. 2005 Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates. Zhonghua Fu Chan Ke Za Zhi 40, N 9:585–590.
[58] Farina A., Sekizawa A., Purwosunu Y., Rizzo N., Banzola I., Concu M., Morano D., Giommi F., Bevini M., Mabrook M., Carinci P., Okai T. 2006 Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls Prenat. Diagn 26, N 12:1115–1120.
[59] Armstrong R. A., Reynolds R. M., Leask R., Shearing C. H., Calder A. A., Riley S. C. 2009 Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia Prenat. Diagn 29, N 10:982–985.
[60] Smith M. S., True C., Grove K. L. 2010 The neuroendocrine basis of lactation-induced suppression of GnRH: role of kisspeptin and leptin Brain Res 1364:139–152.
[61] Evans J. J., Anderson G. M. 2012 Balancing ovulation and anovulation: integration of the reproductive and energy balance axes by neuropeptides Hum. Reprod. Update 18, N 3:313–332.
[62] Wagner G. C., Johnston J. D., Clarke I. J., Lincoln G. A., Hazlerigg D. G. 2008 Redefining the limits of day length responsiveness in a seasonal mammal Endocrinology 149, N 1:32–39.
[63] Castellano J. M., Navarro V. M., Fernandez-Fernandez R., Nogueiras R., Tovar S., Roa J., Vazquez M. J., Vigo E., Casanueva F. F., Aguilar E., Pinilla L., Dieguez C., Tena-Sempere M. 2005 Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 146, N 9:3917–3925.
[64] Greives T. J., Mason A. O., Scotti M. A., Levine J., Ketterson E. D., Kriegsfeld L. J., Demas G. E. 2007 Environmental control of kisspeptin: implications for seasonal reproduction Endocrinology 148, N 3:1158–1166.
[65] Revel F. G., Ansel L., Klosen P., Saboureau M., Pevet P., Mikkelsen J. D., Simonneaux V. 2007 Kisspeptin: a key link to seasonal breeding Rev. Endocr. Metab. Disord 8, N 1:57–65.
[66] Smith J. T., Clay C. M., Caraty A., Clarke I. J. 2007 KiSS-1 messenger ribonucleic acid expression in the hypothalamus of the ewe is regulated by sex steroids and season Endocrinology 148, N. 3:1150–1157.
[67] Castellano J. M., Bentsen A. H., Sanchez-Garrido M. A., RuizPino F., Romero M., Garcia-Galiano D., Aguilar E., Pinilla L., Dieguez C., Mikkelsen J. D., Tena-Sempere M. 2011 Early metabolic programming of puberty onset: impact of changes in postnatal feeding and rearing conditions on the timing of puberty and development of the hypothalamic kisspeptin system Endocrinology 152, N 9 P. 3396–3408.
[68] Castellano J. M., Bentsen A. H., Mikkelsen J. D., Tena-Sempere M. 2010 Kisspeptins: bridging energy homeostasis and reproduction Brain Res 1364 P. 129–138.
[69] Meczekalski B., Podfigurna-Stopa A., Riccardo Genazzani A. 2011 Why kisspeptin is such important for reproduction? Gynecol. Endocrinol 27, N 1:8–13.
[70] Brennan A. M., Mantzoros C. S. 2006 Drug Insight: the role of leptin in human physiology and pathophysiology – emerging clinical applications Nat. Clin. Pract. Endocrinol. Metab 2, N 6 P. 318–327.
[71] Wang M. Y., Chen L., Clark G. O., Lee Y., Stevens R. D., Ilkayeva O. R., Wenner B. R., Bain J. R., Charron M. J., Newgard C. B., Unger R. H. 2010 Leptin therapy in insulin-deficient type I diabetes Proc. Natl Acad. Sci. USA 107, N 11 P. 4813–4819.
[72] Mars M., de Graaf C., de Groot C. P., van Rossum C. T., Kok F. J. 2006 Fasting leptin and appetite responses induced by a 4-day 65 %energy-restricted diet Int. J. Obes. (Lond) 30, N 1 P. 122–128.
[73] Margetic S., Gazzola C., Pegg G. G., Hill R. A. 2002 Leptin: a review of its peripheral actions and interactions Int. J. Obes. Relat. Metab. Disord 26, N 11 P. 1407–1433.
[74] Anifandis G., Koutselini E., Louridas K., Liakopoulos V., Leivaditis K., Mantzavinos T., Sioutopoulou D., Vamvakopoulos N. 2005 Estradiol and leptin as conditional prognostic IVF markers Reproduction 129, N 4 P. 531–534.
[75] Lo K. M., Zhang J., Sun Y., Morelli B., Lan Y., Lauder S., Brunkhorst B., Webster G., Hallakou-Bozec S., Doare L., Gillies S. D. 2005 Engineering a pharmacologically superior form of leptin for the treatment of obesity Protein Eng. Des. Sel 18, N 1 P. 1–10.
[76] Hausman G. J., Barb C. R., Lents C. A. 2012 Leptin and reproductive function Biochimie 94, N 10 P. 2075–2081.
[77] Louis G. W., Greenwald-Yarnell M., Phillips R., Coolen L. M., Lehman M. N., Myers M. G. Jr. 2011 Molecular mapping of the neural pathways linking leptin to the neuroendocrine reproductive axis Endocrinology 152, N 6 P. 2302–2310.
[78] Hausman G. J., Barb C. R. 2010 Adipose tissue and the reproductive axis: biological aspects Endocr. Dev 19 P. 31–44.
[79] de Roux N., Genin E., Carel J. C., Matsuda F., Chaussain J. L., Milgrom E. 2003 Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54 Proc. Natl Acad. Sci. USA 100, N 19:10972–10976.
[80] Funes S., Hedrick J. A., Vassileva G., Markowitz L., Abbondanzo S., Golovko A., Yang S., Monsma F. J., Gustafson E. L. 2003 The KiSS1 receptor GPR54 is essential for the development of the murine reproductive system Biochem. Biophys. Res. Commun 312, N 4:1357–1363.
[81] d'Anglemont de Tassigny X., Fagg L. A., Dixon J. P., Day K., Leitch H. G., Hendrick A. G., Zahn D., Franceschini I., Caraty A., Carlton M. B., Aparicio S. A., Colledge W. H. 2007 Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene Proc. Natl Acad. Sci. USA 104, N 25:10714– 10719.
[82] Lapatto R., Pallais J. C., Zhang D., Chan Y. M., Mahan A., Cerrato F., Le W. W., Hoffman G. E., Seminara S. B. 2007 Kiss1–/– mice exhibit more variable hypogonadism than Gpr54–/– mice Endocrinology 148, N 10:4927–4936.
[83] Navarro V. M., Fernandez-Fernandez R., Castellano J. M., Roa J., Mayen A., Barreiro M. L., Gaytan F., Aguilar E., Pinilla L., Dieguez C., Tena-Sempere M. 2004 Advanced vaginal opening and precocious activation of the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54 J. Physiol 561, Pt 2:379–386.
[84] Clarkson J., Herbison A. E. 2006 Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons Endocrinology 147, N 12:5817–5825.
[85] Han S. K., Gottsch M. L., Lee K. J., Popa S. M., Smith J. T., Jakawich S. K., Clifton D. K., Steiner R. A., Herbison A. E. 2005 Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty J. Neurosci 25, N 49:11349–11356.
[86] Stevenson T. J., Hahn T. P., Macdougall-Shackleton S. A., Ball G. F. 2012 Gonadotropin-releasing hormone plasticity: A comparative perspective Front Neuroendocrinol 33, N 3 P. 287–300.
[87] Richard N., Corvaisier S., Camacho E., Kottler M. L. 2009 KiSS-1 and GPR54 at the pituitary level: overview and recent insights Peptides 30, N 1:123–129.
[88] Migaud H., Ismail R., Cowan M., Davie A. Kisspeptin and seasonal control of reproduction in male European sea bass (Dicentrarchus labrax) Gen. Comp. Endocrinol 179, N 3 P. 384–399.
[89] Kauffman A. S., Park J. H., McPhie-Lalmansingh A. A., Gottsch M. L., Bodo C., Hohmann J. G., Pavlova M. N., Rohde A. D., Clifton D. K., Steiner R. A., Rissman E. F. 2007 The kisspeptin receptor GPR54 is required for sexual differentiation of the brain and behavior J. Neurosci 27, N 33:8826–8835.
[90] Gottsch M. L., Cunningham M. J., Smith J. T., Popa S. M., Acohido B. V., Crowley W. F., Seminara S., Clifton D. K., Steiner R. A. 2004 A role for kisspeptins in the regulation of gonadotropin secretion in the mouse Endocrinology 145, N 9:4073–4077.
[91] Messager S., Chatzidaki E. E., Ma D., Hendrick A. G., Zahn D., Dixon J., Thresher R. R., Malinge I., Lomet D., Carlton M. B., Colledge W. H., Caraty A., Aparicio S. A. 2005 Kisspeptin directly stimulates gonadotropin-releasing hormone release via G proteincoupled receptor 54 Proc. Natl Acad. Sci. USA 102, N 5:1761–1766.
[92] Navarro V. M., Castellano J. M., Fernandez-Fernandez R., Tovar S., Roa J., Mayen A., Barreiro M. L., Casanueva F. F., Aguilar E., Dieguez C., Pinilla L., Tena-Sempere M. 2005 Effects of KiSS1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secretion in the rat Endocrinology 146, N 4:1689–1697.
[93] Navarro V. M., Castellano J. M., Fernandez-Fernandez R., Tovar S., Roa J., Mayen A., Nogueiras R., Vazquez M. J., Barreiro M. L., Magni P., Aguilar E., Dieguez C., Pinilla L.,Tena-Sempere M. 2005 Characterization of the potent luteinizing hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54 Endocrinology 146, N 1:156–163.
[94] Thompson E. L., Patterson M., Murphy K. G., Smith K. L., Dhillo W. S., Todd J. F., Ghatei M. A., Bloom S. R. 2004 Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis J. Neuroendocrinol 16, N 10:850–858.
[95] Thompson E. L., Murphy K. G., Patterson M., Bewick G. A., Stamp G. W., Curtis A. E., Cooke J. H., Jethwa P. H., Todd J. F., Ghatei M. A., Bloom S. R. 2006 Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats Am. J. Physiol. Endocrinol. Metab 291, N 5 E1074– 1082.
[96] Plant T. M., Ramaswamy S., Dipietro M. J. 2006 Repetitive activation of hypothalamic G protein-coupled receptor 54 with intravenous pulses of kisspeptin in the juvenile monkey (Macaca mulatta) elicits a sustained train of gonadotropin-releasing hormone discharges Endocrinology 147, N 2:1007–1013.
[97] Seminara S. B., Dipietro M. J., Ramaswamy S., Crowley W. F. Jr., Plant T. M. 2006 Continuous human metastin 45–54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications Endocrinology 147, N 5:2122–2126.
[98] Caraty A., Smith J. T., Lomet D., Ben Said S., Morrissey A., Cognie J., Doughton B., Baril G., Briant C., Clarke I. J. 2007 Kisspeptin synchronizes preovulatory surges in cyclical ewes and causes ovulation in seasonally acyclic ewes Endocrinology 148, N 11:5258–5267.
[99] Lents C. A., Heidorn N. L., Barb C. R., Ford J. J. 2008 Central and peripheral administration of kisspeptin activates gonadotropin but not somatotropin secretion in prepubertal gilts Reproduction 135, N 6:879–887.
[100] Hashizume T., Saito H., Sawada T., Yaegashi T., Ezzat A. A., Sawai K., Yamashita T. 2010 Characteristics of stimulation of gonadotropin secretion by kisspeptin-10 in female goats Anim. Reprod. Sci 118, N 1:37–41.
[101] Irwig M.S., Fraley G.S., Smith J. T., Acohido B. V., Popa S. M., Cunningham M. J., Gottsch M. L., Clifton D. K., Steiner R. A. 2004 Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat Neuroendocrinology 80, N 4:264–272.
[102] Parhar I. S., Ogawa S., Sakuma Y. Laser-captured single digoxigenin-labeled neurons of gonadotropin-releasing hormone types reveal a novel G protein-coupled receptor (Gpr54) during maturation in cichlid fish Endocrinology 2004 145, N 8 P. 3613–3618.
[103] Dungan H. M., Gottsch M. L., Zeng H., Gragerov A., Bergmann J. E., Vassilatis D. K., Clifton D. K., Steiner R. A. The role of kisspeptin-GPR54 signaling in the tonic regulation and surge release of gonadotropin-releasing hormone/luteinizing hormone J. Neurosci 2007 27, N 44:12088–12095.
[104] d'Anglemont de Tassigny X., Fagg L. A., Carlton M. B., Colledge W. H. Kisspeptin can stimulate gonadotropin-releasing hormone (GnRH) release by a direct action at GnRH nerve terminals Endocrinology 2008 149, N 8:3926–3932.
[105] Anjum S., Krishna A., Sridaran R., Tsutsui K. Localization of Gonadotropin-releasing hormone (GnRH), gonadotropin-inhibitory hormone (GnIH), kisspeptin and GnRH receptor and their possible roles in testicular activities from birth to senescence in mice J. Exp. Zool. A Ecol. Genet. Physiol 2012 317, N 10 P. 630–644.
[106] Zhang C., Roepke T. A., Kelly M. J., Ronnekleiv O. K. Kisspeptin depolarizes gonadotropin-releasing hormone neurons through activation of TRPC-like cationic channels J. Neurosci 2008 28, N 17:4423–4434.
[107] Quaynor S., Hu L., Leung P. K., Feng H., Mores N., Krsmanovic L. Z., Catt K. J. Expression of a functional G protein-coupled receptor 54-kisspeptin autoregulatory system in hypothalamic gonadotropin-releasing hormone neurons Mol. Endocrinol 2007 21, N 12:3062–3070.
[108] Dumalska I., Wu M., Morozova E., Liu R., van den Pol A., Alreja M. Excitatory effects of the puberty-initiating peptide kisspeptin and group I metabotropic glutamate receptor agonists differentiate two distinct subpopulations of gonadotropin-releasing hormone neurons J. Neurosci 2008 28, N 32:8003–8013.
[109] Liu X., Lee K., Herbison A. E. Kisspeptin excites gonadotropinreleasing hormone neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels Endocrinology 2008 149, N 9:4605–4614.
[110] Pielecka-Fortuna J., Chu Z., Moenter S. M. Kisspeptin acts directly and indirectly to increase gonadotropin-releasing hormone neuron activity and its effects are modulated by estradiol Endocrinology 2008 149, N 4:1979–1986.
[111] Shibata M., Friedman R., Ramaswamy S., Plant T. M. Evidence that down regulation of hypothalamic KiSS-1 expression is involved in the negative feedback action of testosterone to regulate luteinising hormone secretion in the adult male rhesus monkey (Macaca mulatta) J. Neuroendocrinol 2007 19, N 6 P. 432–438.
[112] Rometo A. M., Krajewski S. J., Voytko M. L., Rance N. E. Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys J. Clin. Endocrinol. Metabol 2007 92, N 7:2744–2750.
[113] Smith J. T., Dungan H. M., Stoll E. A., Gottsch M. L., Braun R. E., Eacker S. M., Clifton D. K., Steiner R. A. Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse Endocrinology 2005 146, N 7:2976–2984.
[114] Roa J., Vigo E., Castellano J. M., Gaytan F., Navarro V. M., Aguilar E., Dijcks F. A., Ederveen A. G., Pinilla L., van Noort P. I., Tena-Sempere M. Opposite roles of estrogen receptor (ER)alpha and ERbeta in the modulation of luteinizing hormone responses to kisspeptin in the female rat: implications for the generation of the preovulatory surge Endocrinology 2008 149, N 4:1627–1637.
[115] Estrada K. M., Clay C. M., Pompolo S., Smith J. T., Clarke I. J. Elevated KiSS-1 expression in the arcuate nucleus prior to the cyclic preovulatory gonadotrophin-releasing hormone/lutenising hormone surge in the ewe suggests a stimulatory role for kisspeptin in oestrogen-positive feedback J. Neuroendocrinol 2006 18, N 10:806–809.
[116] Pompolo S., Pereira A., Estrada K. M., Clarke I. J. Colocalization of kisspeptin and gonadotropin-releasing hormone in the ovine brain Endocrinology 2006 147, N 2:804–810.
[117] Grachev P., Li X. F, Lin Y. S., Hu M. H., Elsamani L., Paterson S. J., Millar R. P., Lightman S. L., O'Byrne K. T. GPR54-dependent stimulation of luteinizing hormone secretion by neurokinin B in prepubertal rats PLoS One 2012 7, N 8 e44344.
[118] Matvienko M. G., Pustovalov A. S., Buzynska N. O., Dzerzhynsky M. E. Morphofunctional changes in rat testes under kisspeptin influence against blockade and activation of alpha-adrenergic receptors and melatonin administration. X Int. interdisciplinary sci. conf. of students and young scientists (19–23 March 2012, Kyiv) Kyiv, 2012:206–207.
[119] Dzerzhinsky M., Pustovalov A., Matvienko M. Morphofunctional changes in rat testes under kisspeptin influence against blockade and activation of alpha-adrenergic receptors and melatonin administration. Reproduction in Domestic Animals 2012 47, N 2:20.